Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination
- PMID: 38852034
- DOI: 10.1016/j.vaccine.2024.05.063
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination
Abstract
Background: Multisystem inflammatory syndrome associated to Covid-19 (MIS-C) is one of the most severe outcomes of SARS-CoV-2 in children. Covid-19 vaccines were successfully implemented in Chile for the pediatric population since 2021, using both mRNA and inactivated platforms. Effectiveness against MIS-C has been reported for mRNA vaccines. The aim of this study was to describe the epidemiologic trend of MIS-C in Chile during Covid-19 pandemic, both before and after the availability of vaccination for children.
Materials and methods: Analytic study of MIS-C cases from April 2020 to December 2022. Epidemiological data, SARS-CoV-2 variants and vaccination uptake information were obtained from the Epidemiology Department-Ministry of Health, Institute of Public Health and the National Immunization Program, respectively.
Results: 496 cases of MIS-C were reported, 58 % males. Median age was 5 years and most frequent age-cohorts were 6-11 and 0-2 years old with a 33 % each. After the introduction of the Covid-19 vaccine, most cases occurred in children aged 0-2 years. Incidence rates were 3.8, 5.4 and 1.7 per 100,000 inhabitants in 2020, 2021 and 2022, respectively. 97 % of cases (481) occurred in unvaccinated subjects. On those previously vaccinated (15), all but one case occurred in children receiving the inactivated vaccine. No association among circulating variants and incidence was observed. Incidence rate reduction (IRR) comparison between 2020 and 2021-2022 periods was 0.72 (CI 95 % 0.65-0.81, p < 0.05) overall; 0.86 for 0-2 years (CI 95 %:0.71-1; p = 0.12); 0.88 for 3-5 years (CI 95 %:0.69-1.11; p = 0.28); 0.61 for 6-11 years (CI 95 %: 0.50-0.75; p < 0.05); and 0.64 for 12-17 years (CI 95 %:0.47-0.89; p < 0.05), consistent with vaccination uptake during the studied period: 63 % for 3-5 years, 91 % for 6-11 years, and 99 % for 12-17 years.
Conclusions: A decline of MIS-C incidence and a shift to younger, unvaccinated population overtime was observed. IRR decreased in age-cohorts which achieved high vaccination rates.
Keywords: Children; Covid-19; Multisystem inflammatory syndrome; Vaccines.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Rodolfo Villena reports a relationship with Sinovac Biotech Ltd that includes: funding grants. Rodolfo Villena reports a relationship with Pfizer that includes: speaking and lecture fees. Rodolfo Villena reports a relationship with Janssen Pharmaceuticals Inc that includes: funding grants. Giannina Izquierdo reports a relationship with Pfizer Inc that includes: speaking and lecture fees. Juan Pablo Torres reports a relationship with Pfizer that includes: speaking and lecture fees If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Multisystemic inflammatory syndrome in children and the BNT162b2 vaccine: a nationwide cohort study.Eur J Pediatr. 2024 Aug;183(8):3319-3326. doi: 10.1007/s00431-024-05586-4. Epub 2024 May 9. Eur J Pediatr. 2024. PMID: 38724677
-
Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California.Vaccine. 2025 Jan 1;43(Pt 1):126499. doi: 10.1016/j.vaccine.2024.126499. Epub 2024 Nov 7. Vaccine. 2025. PMID: 39515133
-
Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study.J Korean Med Sci. 2025 Jan 20;40(3):e10. doi: 10.3346/jkms.2025.40.e10. J Korean Med Sci. 2025. PMID: 39834222 Free PMC article.
-
Routine SARS-CoV-2 vaccination for all children.Immunol Rev. 2022 Aug;309(1):90-96. doi: 10.1111/imr.13108. Epub 2022 Jul 7. Immunol Rev. 2022. PMID: 35799475 Free PMC article. Review.
-
Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature.Ital J Pediatr. 2024 Sep 27;50(1):194. doi: 10.1186/s13052-024-01758-y. Ital J Pediatr. 2024. PMID: 39334454 Free PMC article. Review.
Cited by
-
Dynamics of Multisystem Inflammatory Syndrome in Children (MIS-C) associated to COVID-19: steady severity despite declining cases and new SARS-CoV-2 variants-a single-center cohort study.Eur J Pediatr. 2025 May 7;184(6):327. doi: 10.1007/s00431-025-06153-1. Eur J Pediatr. 2025. PMID: 40332604 Free PMC article.
-
Parental hesitancy for pediatric COVID-19 vaccines in Chile.Ther Adv Vaccines Immunother. 2025 Mar 12;13:25151355251322312. doi: 10.1177/25151355251322312. eCollection 2025. Ther Adv Vaccines Immunother. 2025. PMID: 40078505 Free PMC article.
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous